Stockscreener 앱 받기
1.93
12.54%
0.215
전일 마감가:
$1.715
열려 있는:
$1.75
하루 거래량:
152.89K
Relative Volume:
1.14
시가총액:
$72.59M
수익:
-
순이익/손실:
$-13.27M
주가수익비율:
-11.77
EPS:
-0.164
순현금흐름:
$-7.70M
1주 성능:
-1.03%
1개월 성능:
-24.90%
6개월 성능:
+2.66%
1년 성능:
+90.84%
1일 변동 폭
$1.75
$1.93
1주일 범위
$1.71
$2.09
52주 변동 폭
$0.9016
$3.349
Okyo Pharma Limited Stock (OKYO) Company Profile
OKYO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OKYO
Okyo Pharma Limited
|
1.93 | 64.50M | 0 | -13.27M | -7.70M | -0.164 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Okyo Pharma Limited 주식(OKYO)의 최신 뉴스
What is the fair value estimate for OKYO Pharma Limited (OK11) stock in 2025Market Sentiment Report & Technical Pattern Alert System - Newser
How OKYO Pharma Limited (OK11) stock compares with top peersGlobal Markets & Long-Term Safe Investment Plans - Newser
Is OKYO Pharma Limited (OK11) stock a top pick for value investors2025 Trade Ideas & AI Powered Market Entry Strategies - Newser
Is OKYO Pharma Limited stock trading near support levelsWeekly Profit Analysis & Daily Chart Pattern Signal Reports - Newser
Okyo Pharma chairman acquires 27,051 company shares - TipRanks
OKYO Pharma chairman-linked entity acquires additional shares on NASDAQ - Investing.com
OKYO Pharma’s Chairman Increases Stake Amidst Phase 2 Trial Completion - TipRanks
Gabriele Cerrone increases stake in OKYO Pharma with share purchase - Investing.com
OKYO Pharma Limited Executive Chairman Gabriele Cerrone Acquires Additional Shares in Company - Quiver Quantitative
Gabriele Cerrone increases stake in OKYO Pharma with share purchase By Investing.com - Investing.com UK
OKYO Pharma (NASDAQ: OKYO) chairman raises holding after buying 27,051 shares - Stock Titan
OKYO Pharma Announces Chairman and Founder Acquires Shares - Yahoo Finance Australia
Why OKYO Pharma Limited stock is a must watch in 2025Market Growth Report & Comprehensive Market Scan Reports - Newser
OKYO Pharma executive chair increases stake with additional share purchase - Proactive financial news
Holdings of OKYO Pharma Limited (OKYO) are aligned with the stars - Setenews
Decliners Report: Will OKYO Pharma Limited stock remain a Wall Street favoriteRecession Risk & Advanced Swing Trade Entry Plans - BỘ NỘI VỤ
Panetta Partners increases stake in OKYO Pharma with purchase of 82,018 shares - Investing.com Australia
Operating cash flow per share of OKYO Pharma Limited – NASDAQ:OKYO - TradingView
Okyo Pharma chairman increases stake with new share acquisition By Investing.com - Investing.com Nigeria
OKYO Pharma stock rises after Chairman increases stake By Investing.com - Investing.com Nigeria
OKYO Pharma stock rises after Chairman increases stake - Investing.com India
OKYO Pharm Chairman and Founder acquires shares - MSN
OKYO Pharma’s Chairman Increases Stake with Recent Share Acquisition - TipRanks
Okyo Pharma chairman acquires 82,018 company shares - TipRanks
Okyo Pharma chairman increases stake with new share acquisition - Investing.com India
OKYO Pharma founder increases his buys shares - Proactive financial news
OKYO Pharma Limited Executive Chairman Acquires Additional Shares, Totaling 10.5 Million Holdings - Quiver Quantitative
Is OKYO Pharma Limited (OK11) stock trading at attractive multiples2025 Pullback Review & Capital Efficient Trade Techniques - newser.com
Why OKYO Pharma Limited (OK11) stock signals breakout potential2025 Big Picture & Fast Gaining Stock Reports - newser.com
Dry Eye Disease Market Size was ~USD 3.76 Billion in 2023 and expected to Grow by 2034, Analysed DelveInsight - Barchart.com
Is OKYO Pharma Limited stock oversold or undervaluedRisk Management & Stepwise Trade Signal Implementation - newser.com
Key metrics from OKYO Pharma Limited’s quarterly dataPortfolio Return Summary & Safe Entry Zone Identification - newser.com
Why OKYO Pharma Limited stock is favored by top institutionsMarket Performance Report & Daily Stock Momentum Reports - newser.com
Has OKYO Pharma Limited found a price floorJuly 2025 Trade Ideas & Technical Entry and Exit Alerts - newser.com
Will OKYO Pharma Limited stock deliver better than expected guidanceDividend Hike & AI Driven Stock Reports - newser.com
OKYO Pharma Limited stock chart pattern explainedStop Loss & Daily Stock Trend Reports - newser.com
Okyo Pharma Limited (OKYO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.10%
1.10%
자본화:
|
볼륨(24시간):